cover
Article Per Year (5 Year)
All
Home Page
OAI Link
Editorial Team
Contact
Reviewer
Google Scholar
Contact Name
Rachmat Hidayat
Contact Email
dr.rachmat.hidayat@gmail.com
Phone
+6281949581088
Journal Mail Official
indonesian.medical.reviews@gmail.com
Editorial Address
Jl. Sirna Raga no 99, 8 Ilir, Ilir Timur 3, Palembang
Location
Kota palembang,
Sumatera selatan
INDONESIA
Open Access Indonesian Journal of Medical Reviews
Published by HM Publisher
ISSN : -     EISSN : 28076257     DOI : https://doi.org/10.37275/oaijmr
Core Subject : Health,
Health Professions Medicine & Pharmacology
Open Access Indonesian Journal of Medical Reviews (OAIJMR) is a bi-monthly, international, peer-review, and open access journal dedicated to various disciplines of medicine, biology and life sciences. The journal publishes all type of review articles, narrative review, meta-analysis, systematic review, mini-reviews and book review.
Arjuna Subject : Kedokteran - Kedokteran (Lain-Lain)
Articles 213 Documents
 18   19   20   21   22 
Efficacy and Safety of Psilocybin-Assisted Therapy for Depression: A Meta-Analysis of Randomised Controlled Trials Siti Nashria Rusdhy; Andrian Fajar Kusumadewi; Carla Raymondalexas Marchira; Mustika Suci Mahardikaningrum; Teresa Lalita Wiryarini; Devira Ayu Wulandari
Open Access Indonesian Journal of Medical Reviews Vol. 6 No. 2 (2026): Open Access Indonesian Journal of Medical Reviews
Publisher : HM Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37275/oaijmr.v6i2.883

Abstract

Psilocybin-assisted therapy shows promise for depression, though current evidence relies on Phase 2 trials with notable methodological limitations. We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) evaluating psilocybin-assisted therapy for major or treatment-resistant depression up to February 2024. We evaluated depressive symptom severity using random-effects meta-analysis, moderator analyses, Cochrane Risk of Bias 2, and GRADE methodology. Nine RCTs (N=514) were included. Psilocybin therapy demonstrated a large pooled effect size for symptom reduction (SMD = 1.270, 95% CI: 0.865–1.676, p<0.001). However, substantial heterogeneity was observed (I² = 79.1%). Comparator type significantly moderated outcomes, with waitlist controls showing substantially larger effects than active/placebo controls. Overall GRADE certainty of evidence was rated LOW due to risk of bias, heterogeneity, short-term outcomes, and publication bias concerns. In conclusion, while psilocybin-assisted therapy yields a large pooled effect estimate for depression, current findings are preliminary. Results are heavily qualified by methodological constraints, including waitlist-inflated efficacy, compromised blinding from subjective psychedelic effects, and the confounding influence of integrated psychological support. Confirmation through robust Phase 3 trials is required before supporting routine clinical implementation.
Semaglutide and the Risk of Non-Arteritic Anterior Ischaemic Optic Neuropathy: A Systematic Review and Meta-Analysis Jovita Jutamulia; Elfira Sutanto
Open Access Indonesian Journal of Medical Reviews Vol. 6 No. 2 (2026): Open Access Indonesian Journal of Medical Reviews
Publisher : HM Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37275/oaijmr.v6i2.884

Abstract

Semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA), has emerged as an effective treatment for type 2 diabetes mellitus and obesity management. However, recent pharmacovigilance and observational studies have raised concerns regarding a potential association between semaglutide use and non-arteritic anterior ischaemic optic neuropathy (NAION), a serious form of optic neuropathy causing sudden vision loss. We conducted a systematic review and meta-analysis of observational studies examining the association between semaglutide exposure and NAION risk. We searched PubMed, Embase, and Google Scholar without date restrictions, with the final search completed on 31 March 2026. Study selection was based on predefined inclusion criteria, and quality was assessed using the Newcastle-Ottawa Scale (NOS). A random-effects model was used to estimate pooled hazard ratios (HR) with 95% confidence intervals (CI). Heterogeneity was quantified using the I² statistic. Publication bias was examined using funnel plots and Egger’s regression test. Six observational studies comprising 699,141 participants were included in the meta-analysis. Overall, semaglutide was associated with a significantly increased risk of NAION (pooled HR 1.802; 95% CI 1.221–2.658; p = 0.003). Substantial heterogeneity was observed (I² = 72.8%, Q = 18.37, p = 0.003). Subgroup analyses revealed that the positive association was driven by four prospective cohort studies reporting elevated NAION risk (HR = 2.402; 95% CI 1.662–3.468), whereas two retrospective studies reported null associations (HR = 0.98; 95% CI 0.60–1.60). Sensitivity analyses demonstrated robustness of the primary finding. In conclusion, this meta-analysis provides evidence of a potential increased risk of NAION associated with semaglutide use in observational studies, particularly among individuals with type 2 diabetes and obesity. Clinical awareness of this signal is warranted, and further prospective investigation is recommended.
Ultrasound-Guided Combined Femoral and Popliteal-Sciatic Nerve Block for Foot Debridement in a Patient with Peripheral Arterial Disease, Heart Failure with Reduced Ejection Fraction, and Pulmonary Oedema: A High-Risk Case Report Heri Dwi Purnomo; Paramita Putri Hapsari; Muhammad Rizal Aulia
Open Access Indonesian Journal of Medical Reviews Vol. 6 No. 2 (2026): Open Access Indonesian Journal of Medical Reviews
Publisher : HM Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37275/oaijmr.v6i2.888

Abstract

Peripheral arterial disease (PAD) in its advanced stage leads to critical limb ischaemia requiring operative debridement, and coexisting heart failure with reduced ejection fraction (HFrEF) and pulmonary oedema make general and neuraxial anaesthesia hazardous. We describe a 59-year-old man with three-vessel coronary artery disease previously treated by multiple percutaneous coronary interventions, HFrEF (ejection fraction 36%), hypertension, diabetes mellitus and bilateral PAD who presented with acute decompensated heart failure, pulmonary oedema and bilateral pleural effusion together with an extensive left foot ulcer requiring urgent debridement and necrotomy. An ultrasound-guided combined femoral and popliteal-sciatic nerve block was performed using 20 mL of 1.5% lidocaine and 20 mL of 0.25% bupivacaine. The patient remained conscious and haemodynamically stable with systolic blood pressure 90–110 mmHg, heart rate ~85 beats/min and SpO₂ 100%. The 60-minute procedure was uneventful with no local anaesthetic toxicity, new neurological deficit or respiratory compromise, and the patient was transferred to the high-care unit. Ultrasound-guided peripheral nerve blockade represents a cardiopulmonary-sparing anaesthetic strategy that can deliver adequate operating conditions for lower-extremity surgery in patients with PAD and severe cardiac and respiratory comorbidity. Keywords: Peripheral nerve block, Peripheral arterial disease, Heart failure with reduced ejection fraction, regional anesthesia, ultrasound guidance.

Page 22 of 22 | Total Record : 213

 18   19   20   21   22 

Filter by Year

2021 2026


Reset
Filter By Issues
All Issue Vol. 6 No. 2 (2026): Open Access Indonesian Journal of Medical Reviews Vol. 6 No. 1 (2026): Open Access Indonesian Journal of Medical Reviews Vol. 5 No. 6 (2025): Open Access Indonesian Journal of Medical Reviews Vol. 5 No. 5 (2025): Open Access Indonesian Journal of Medical Reviews Vol. 5 No. 4 (2025): Open Access Indonesian Journal of Medical Reviews Vol. 5 No. 3 (2025): Open Access Indonesian Journal of Medical Reviews Vol. 5 No. 2 (2025): Open Access Indonesian Journal of Medical Reviews Vol. 5 No. 1 (2025): Open Access Indonesian Journal of Medical Reviews Vol. 4 No. 6 (2024): Open Access Indonesian Journal of Medical Reviews Vol. 4 No. 5 (2024): Open Access Indonesian Journal of Medical Reviews Vol. 4 No. 4 (2024): Open Access Indonesian Journal of Medical Reviews Vol. 4 No. 3 (2024): Open Access Indonesian Journal of Medical Reviews Vol. 4 No. 2 (2024): Open Access Indonesian Journal of Medical Reviews Vol. 4 No. 1 (2024): Open Access Indonesian Journal of Medical Reviews Vol. 3 No. 6 (2023): Open Access Indonesian Journal of Medical Reviews Vol. 3 No. 5 (2023): Open Access Indonesian Journal of Medical Reviews Vol. 3 No. 4 (2023): Open Access Indonesian Journal of Medical Reviews Vol. 3 No. 3 (2023): Open Access Indonesian Journal of Medical Reviews Vol. 3 No. 2 (2023): Open Access Indonesian Journal of Medical Reviews Vol. 3 No. 1 (2023): Open Access Indonesian Journal of Medical Reviews Vol. 2 No. 6 (2022): Open Access Indonesian Journal of Medical Reviews Vol. 2 No. 5 (2022): Open Access Indonesian Journal of Medical Reviews Vol. 2 No. 4 (2022): Open Access Indonesian Journal of Medical Reviews Vol. 2 No. 3 (2022): Open Access Indonesian Journal of Medical Reviews Vol. 2 No. 2 (2022): Open Access Indonesian Journal of Medical Reviews Vol. 2 No. 1 (2022): Open Access Indonesian Journal of Medical Reviews Vol. 1 No. 6 (2021): Open Access Indonesian Journal of Medical Reviews Vol. 1 No. 5 (2021): Open Access Indonesian Journal of Medical Reviews Vol. 1 No. 4 (2021): Open Access Indonesian Journal of Medical Reviews Vol. 1 No. 3 (2021): Open Access Indonesian Journal of Medical Reviews Vol. 1 No. 2 (2021): Open Access Indonesian Journal of Medical Reviews Vol. 1 No. 1 (2021): Open Access Indonesian Journal of Medical Reviews More Issue